Avraham Hampel
Corporate Officer/Principal at STEAKHOLDER FOODS LTD.
Profile
Avraham Hampel is currently the Secretary at BioCancell Therapeutics, Inc. and the Vice President-Corporate Development at Steakholder Foods Ltd.
He previously worked as a Secretary at Anchiano Therapeutics Ltd.
Avraham Hampel active positions
Companies | Position | Start |
---|---|---|
STEAKHOLDER FOODS LTD. | Corporate Officer/Principal | 2020-08-31 |
BioCancell Therapeutics, Inc.
BioCancell Therapeutics, Inc. BiotechnologyHealth Technology BioCancell Therapeutics, Inc. is a development-stage biopharmaceutical company, which is focused on the discovery, development and commercialization of novel therapies for treating cancer-related diseases. The company's technology offers a safe and long-term treatment of cancer, with no adverse effects. The drug candidates developed by the company are targeted and its target is to selectively destroy the cancer cells without affecting healthy cells. BioCancell was founded on July 26, 2004 by Avraham Hochberg and is headquartered in Jerusalem, Israel. | Corporate Secretary | 2009-08-13 |
Former positions of Avraham Hampel
Companies | Position | End |
---|---|---|
ANCHIANO THERAPEUTICS LTD. | Corporate Secretary | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
STEAKHOLDER FOODS LTD. | Consumer Non-Durables |
Private companies | 2 |
---|---|
BioCancell Therapeutics, Inc.
BioCancell Therapeutics, Inc. BiotechnologyHealth Technology BioCancell Therapeutics, Inc. is a development-stage biopharmaceutical company, which is focused on the discovery, development and commercialization of novel therapies for treating cancer-related diseases. The company's technology offers a safe and long-term treatment of cancer, with no adverse effects. The drug candidates developed by the company are targeted and its target is to selectively destroy the cancer cells without affecting healthy cells. BioCancell was founded on July 26, 2004 by Avraham Hochberg and is headquartered in Jerusalem, Israel. | Health Technology |
Anchiano Therapeutics Ltd.
Anchiano Therapeutics Ltd. BiotechnologyHealth Technology Anchiano Therapeutics Ltd. is a clinical-stage biopharmaceutical company, which engages in tin the discovery, development and commercialization of drugs for cancer-related diseases. Its products include two drugs for cancer BC-819 and BC-821. The company was founded by Avraham Hochberg in 2004 and is headquartered in Jerusalem, Israel. | Health Technology |
- Stock Market
- Insiders
- Avraham Hampel